Work

Phase II trial of regorafenib in metastatic medullary thyroid carcinoma (MTC) and radioactive iodine refractory differentiated thyroid carcinoma (RAIR DTC).

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.6109

Authors: Kartik Sehgal, Ruichao Shi, Theodora Pappa, Judy K Min, Liam B Oakley, Anne ONeill, Michael J. Dennis, Hari Anant Deshpande, Robert I. Haddad, Jochen H. Lorch

Institutions: Dana-Farber Cancer Institute, Yale Cancer Center, Northwestern University

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400915955

Cites:

Cited by: 1

Related to: 10